Illumina introduces a revolutionary next-generation sequencing (NGS) and multiomics technology—engineered to deliver deeper insights, accelerate discovery, and push the boundaries of what’s possible in genomics.
Opening remarks
Jacob Thaysen, PhD
CEO
Illumina
0:00 – 4:17
Platforms as our foundation
Sergio Peisajovich, PhD
VP, Head of Protein Engineering & Molecular Sciences R&D
Illumina
4:17 – 16:28
Perspectives on constellation technology for rapid WGS
Stephen Kingsmore, MD, DSc
President and CEO
Rady Children’s Institute for Genomic Medicine
16:28 – 31:22
Redefining multiomics
Cande Rogert, PhD
VP, Global Head of Advanced Sciences
Illumina
31:22 – 47:14
Characterizing alveolar dysregulation in pulmonary fibrosis using Illumina Spatial Technology
Nicholas Banovich, PhD
Associate Professor
Translational Genomics Research Institute (TGen)
47:14 – 58:17
High resolution spatial sequencing reveals changes in prostate tumor environment
Jasmine Plummer, PhD
Director, Center for Spatial Omics
St. Jude Children’s Research Hospital
58:17 – 70:38
Illumina Spatial Technology: Whole-transcriptome profiling of large tissue areas
Michal Lipinski, PhD
Senior Research Scientist
Broad Institute
70:38 – 82:55
Closing remarks
Jacob Thaysen, PhD
CEO
Illumina
82:55 – 84:39
Your email address is never shared with third parties.